MedTrace Logo

Efficacy of a Dedicated Therapeutic Education Program in Patients at High Cardiovascular Risk

NCT01622400 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2018-06-20

No results posted yet for this study

Summary

A dedicated therapeutic education program is an essential tool in the management of hypertension as well as in the control of other cardiovascular risk factors. The purpose of this study is therefore to evaluate the effect of such a therapeutic education program in general practice patients at high cardiovascular risk.

Conditions

Interventions

OTHER

Therapeutic education HTA Vasc

The intervention program takes place in 3 phases. First, the education team realizes an individual educational diagnosis to define the objectives of the intervention according to each patient's needs. Secondly, patients assist to 3 to 5 group sessions lasting 2 hours with a dedicated nurse focusing on medical therapy explanation and blood pressure self measurement education - and with a dedicated nutritionist focusing on stress management and nutrition program. Patients can also have individual consultations with the dedicated nutritionist. Finally, an individual assessment permits to evaluate the benefits of the program for each patient and to define new objectives.

Sponsors & Collaborators

  • Association HTA Vasc

    collaborator OTHER

  • CRESGE (Centre de Recherches Economiques Sociologiques et de Gestion)

    collaborator UNKNOWN

  • CERIM (Centre d'Etudes et de Recherche en Informatique Médicale), P. Devos

    collaborator UNKNOWN

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • FAYOLLE PF Patrick, GP · Arras Principal Investigator

  • GOUDJI GG Gustave, GP · Lille Principal Investigator

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01622400 on ClinicalTrials.gov